WallStreetZenWallStreetZen

NASDAQ: SHAC
Scp & Co Healthcare Acquisition Co Stock

Open Broker Account
$10.05-0.02 (-0.2%)
Updated Dec 5, 2022
SHAC Price
$10.05
Fair Value Price
$10.08
Market Cap
$288.94M
52 Week Low
$9.68
52 Week High
$10.07
P/E
29.56x
P/B
-33.86x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$10.08M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.12
Operating Cash Flow
-$905k
Beta
0.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

SHAC Overview

SCP & CO Healthcare Acquisition Company is a special purpose acquisition company (SPAC) formed to effect mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar combinations with one or more businesses. The company targets companies in the healthcare technology sector in the U.S. and other developed countries. SCP & CO Healthcare Acquisition was incorporated in 2020 and is headquartered in Tampa, FL.

Zen Score

Industry Average (9)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SHAC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SHAC ($10.05) is undervalued by 0.27% relative to our estimate of its Fair Value price of $10.08 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SHAC ($10.05) is not significantly undervalued (0.27%) relative to our estimate of its Fair Value price of $10.08 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SHAC was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SHAC due diligence checks available for Premium users.

Be the first to know about important SHAC news, forecast changes, insider trades & much more!

Valuation

SHAC fair value

Fair Value of SHAC stock based on Discounted Cash Flow (DCF)
Price
$10.05
Fair Value
$10.08
Undervalued by
0.27%
SHAC ($10.05) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SHAC ($10.05) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SHAC was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SHAC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
29.56x
Industry
18.61x
Market
21.63x
SHAC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SHAC is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

SHAC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-33.86x
Industry
-35.12x

SHAC's financial health

Profit margin

Revenue
$0.0
Net Income
$1.1M
Profit Margin
0%
SHAC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$232.4M
Liabilities
$9.6M
Debt to equity
-1.12
SHAC's short-term assets ($874.36k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SHAC's long-term liabilities ($9.04M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SHAC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SHAC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$252.1k
Investing
$194.3k
Financing
$0.0
SHAC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SHAC vs Shell Company Stocks

TickerMarket Cap1d %P/EP/B
ITQ$288.94M+0.05%38.65x-30.02x
SHAC$288.94M-0.15%29.56x-33.86x
ZWRK$289.08M+0.25%52.92x-26.12x
VII$288.79M+0.05%31.39x-28.02x
BIOT$288.65M0.00%38.62x-22.00x

Scp & Co Healthcare Acquisition Co Stock FAQ

What is Scp & Co Healthcare Acquisition Co's quote symbol?

NASDAQ: SHAC) Scp & Co Healthcare Acquisition Co trades on the NASDAQ under the ticker symbol SHAC. Scp & Co Healthcare Acquisition Co stock quotes can also be displayed as NASDAQ: SHAC.

If you're new to stock investing, here's how to buy Scp & Co Healthcare Acquisition Co stock.

What is the 52 week high and low for Scp & Co Healthcare Acquisition Co (NASDAQ: SHAC)?

(NASDAQ: SHAC) Scp & Co Healthcare Acquisition Co's 52-week high was $10.07, and its 52-week low was $9.68. It is currently -0.2% from its 52-week high and 3.82% from its 52-week low.

How much is Scp & Co Healthcare Acquisition Co stock worth today?

(NASDAQ: SHAC) Scp & Co Healthcare Acquisition Co currently has 28,750,000 outstanding shares. With Scp & Co Healthcare Acquisition Co stock trading at $10.05 per share, the total value of Scp & Co Healthcare Acquisition Co stock (market capitalization) is $288.94M.

Scp & Co Healthcare Acquisition Co stock was originally listed at a price of $10.38 in Jan 26, 2021. If you had invested in Scp & Co Healthcare Acquisition Co stock at $10.38, your return over the last 1 years would have been -3.18%, for an annualized return of -3.18% (not including any dividends or dividend reinvestments).

How much is Scp & Co Healthcare Acquisition Co's stock price per share?

(NASDAQ: SHAC) Scp & Co Healthcare Acquisition Co stock price per share is $10.05 today (as of Dec 5, 2022).

What is Scp & Co Healthcare Acquisition Co's Market Cap?

(NASDAQ: SHAC) Scp & Co Healthcare Acquisition Co's market cap is $288.94M, as of Dec 6, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Scp & Co Healthcare Acquisition Co's market cap is calculated by multiplying SHAC's current stock price of $10.05 by SHAC's total outstanding shares of 28,750,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.